microRNA information: hsa-miR-550a-5p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-550a-5p | miRbase |
| Accession: | MIMAT0004800 | miRbase |
| Precursor name: | hsa-mir-550a-1 | miRbase |
| Precursor accession: | MI0003600 | miRbase |
| Symbol: | NA | HGNC |
| RefSeq ID: | NA | GenBank |
| Sequence: | AGUGCCUGAGGGAGUAAGAGCCC |
Reported expression in cancers: hsa-miR-550a-5p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-550a-5p | liver cancer | upregulation | "Our previous study found that miR-550a a frequentl ......" | 23145039 |
Reported cancer pathway affected by hsa-miR-550a-5p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|
Reported cancer prognosis affected by hsa-miR-550a-5p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-550a-5p | breast cancer | metastasis | "Reduced miR 550a 3p leads to breast cancer initiat ......" | 27462780 | |
| hsa-miR-550a-5p | liver cancer | cell migration | "Our previous study found that miR-550a a frequentl ......" | 23145039 |
Reported gene related to hsa-miR-550a-5p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-550a-5p | liver cancer | CPEB4 | "In addition we discovered that cytoplasmic polyade ......" | 23145039 |
| hsa-miR-550a-5p | breast cancer | MAPK3 | "Reduced miR 550a 3p leads to breast cancer initiat ......" | 27462780 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-550a-5p | PTGS1 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.712; TCGA BRCA -0.088; TCGA COAD -0.338; TCGA ESCA -0.39; TCGA HNSC -0.23; TCGA LUAD -0.147; TCGA LUSC -0.365; TCGA THCA -0.217; TCGA STAD -0.439 |
hsa-miR-550a-5p | GIMAP4 | 9 cancers: BLCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; STAD; UCEC | MirTarget | TCGA BLCA -0.208; TCGA CESC -0.187; TCGA COAD -0.294; TCGA ESCA -0.167; TCGA LIHC -0.172; TCGA LUAD -0.106; TCGA LUSC -0.403; TCGA STAD -0.098; TCGA UCEC -0.271 |
hsa-miR-550a-5p | CDH5 | 10 cancers: BLCA; CESC; COAD; LIHC; LUAD; LUSC; OV; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.25; TCGA CESC -0.238; TCGA COAD -0.209; TCGA LIHC -0.179; TCGA LUAD -0.16; TCGA LUSC -0.407; TCGA OV -0.076; TCGA SARC -0.133; TCGA STAD -0.081; TCGA UCEC -0.242 |
hsa-miR-550a-5p | ITPRIP | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.145; TCGA CESC -0.205; TCGA COAD -0.12; TCGA ESCA -0.331; TCGA HNSC -0.147; TCGA LIHC -0.138; TCGA LUAD -0.114; TCGA LUSC -0.208; TCGA PAAD -0.168; TCGA STAD -0.102; TCGA UCEC -0.184 |
hsa-miR-550a-5p | FBXL7 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.453; TCGA BRCA -0.12; TCGA CESC -0.309; TCGA COAD -0.327; TCGA ESCA -0.282; TCGA HNSC -0.122; TCGA LUAD -0.143; TCGA LUSC -0.364; TCGA OV -0.131; TCGA PAAD -0.208; TCGA STAD -0.408; TCGA UCEC -0.519 |
hsa-miR-550a-5p | IGDCC4 | 9 cancers: BLCA; BRCA; CESC; COAD; HNSC; LUSC; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.313; TCGA BRCA -0.08; TCGA CESC -0.329; TCGA COAD -0.205; TCGA HNSC -0.17; TCGA LUSC -0.135; TCGA PAAD -0.366; TCGA STAD -0.147; TCGA UCEC -0.19 |
hsa-miR-550a-5p | THBS3 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; OV; PAAD; SARC; STAD | MirTarget | TCGA BLCA -0.132; TCGA BRCA -0.059; TCGA CESC -0.103; TCGA COAD -0.187; TCGA ESCA -0.181; TCGA LIHC -0.189; TCGA LUAD -0.107; TCGA LUSC -0.075; TCGA OV -0.097; TCGA PAAD -0.172; TCGA SARC -0.119; TCGA STAD -0.176 |
hsa-miR-550a-5p | SLC9A9 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.343; TCGA CESC -0.412; TCGA COAD -0.395; TCGA ESCA -0.506; TCGA HNSC -0.109; TCGA LGG -0.107; TCGA LIHC -0.161; TCGA LUAD -0.131; TCGA LUSC -0.164; TCGA PAAD -0.226; TCGA SARC -0.131; TCGA STAD -0.45; TCGA UCEC -0.319 |
hsa-miR-550a-5p | ATP1A2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -1.178; TCGA BRCA -0.267; TCGA CESC -0.389; TCGA COAD -0.957; TCGA ESCA -1.005; TCGA HNSC -0.756; TCGA LGG -0.248; TCGA LIHC -0.347; TCGA LUAD -0.628; TCGA LUSC -0.584; TCGA PAAD -0.392; TCGA STAD -1.232; TCGA UCEC -0.538 |
hsa-miR-550a-5p | DSTN | 9 cancers: BLCA; ESCA; HNSC; KIRC; LUSC; OV; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.218; TCGA ESCA -0.158; TCGA HNSC -0.135; TCGA KIRC -0.105; TCGA LUSC -0.066; TCGA OV -0.066; TCGA SARC -0.17; TCGA STAD -0.276; TCGA UCEC -0.246 |
hsa-miR-550a-5p | TSHZ3 | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUSC; STAD; UCEC | MirTarget | TCGA BLCA -0.476; TCGA BRCA -0.104; TCGA CESC -0.207; TCGA COAD -0.332; TCGA ESCA -0.446; TCGA LIHC -0.179; TCGA LUSC -0.179; TCGA STAD -0.352; TCGA UCEC -0.475 |
hsa-miR-550a-5p | RIMBP2 | 9 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LGG; LUAD; STAD | MirTarget | TCGA BLCA -0.361; TCGA BRCA -0.243; TCGA COAD -0.403; TCGA HNSC -0.378; TCGA KIRC -0.527; TCGA KIRP -0.412; TCGA LGG -0.278; TCGA LUAD -0.244; TCGA STAD -0.39 |
hsa-miR-550a-5p | FGF1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LGG; LIHC; LUSC; OV; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.275; TCGA BRCA -0.124; TCGA CESC -0.314; TCGA COAD -0.481; TCGA ESCA -0.412; TCGA KIRC -0.543; TCGA LGG -0.104; TCGA LIHC -0.374; TCGA LUSC -0.307; TCGA OV -0.197; TCGA PAAD -0.219; TCGA THCA -0.203; TCGA STAD -0.263; TCGA UCEC -0.326 |
hsa-miR-550a-5p | CHURC1 | 9 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LIHC; LUSC; SARC; UCEC | MirTarget | TCGA BLCA -0.109; TCGA COAD -0.067; TCGA ESCA -0.124; TCGA KIRC -0.062; TCGA KIRP -0.061; TCGA LIHC -0.071; TCGA LUSC -0.089; TCGA SARC -0.08; TCGA UCEC -0.159 |
hsa-miR-550a-5p | KLHL6 | 9 cancers: BLCA; CESC; COAD; ESCA; LUAD; LUSC; PAAD; SARC; THCA | MirTarget | TCGA BLCA -0.162; TCGA CESC -0.191; TCGA COAD -0.352; TCGA ESCA -0.186; TCGA LUAD -0.18; TCGA LUSC -0.493; TCGA PAAD -0.352; TCGA SARC -0.155; TCGA THCA -0.272 |
hsa-miR-550a-5p | CGNL1 | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; STAD; UCEC | MirTarget | TCGA BLCA -0.476; TCGA BRCA -0.114; TCGA CESC -0.294; TCGA COAD -0.204; TCGA HNSC -0.302; TCGA KIRC -0.387; TCGA KIRP -0.265; TCGA LUAD -0.263; TCGA LUSC -0.429; TCGA STAD -0.514; TCGA UCEC -0.349 |
hsa-miR-550a-5p | SORCS2 | 15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.512; TCGA BRCA -0.376; TCGA COAD -0.378; TCGA ESCA -0.499; TCGA HNSC -0.319; TCGA KIRP -0.409; TCGA LGG -0.098; TCGA LIHC -0.275; TCGA LUAD -0.585; TCGA LUSC -0.593; TCGA PAAD -0.478; TCGA SARC -0.266; TCGA THCA -0.28; TCGA STAD -0.345; TCGA UCEC -0.354 |
hsa-miR-550a-5p | BCL2L2 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; SARC; UCEC | MirTarget | TCGA BLCA -0.111; TCGA CESC -0.096; TCGA COAD -0.069; TCGA ESCA -0.2; TCGA HNSC -0.122; TCGA KIRC -0.245; TCGA KIRP -0.15; TCGA LGG -0.175; TCGA LUAD -0.069; TCGA LUSC -0.078; TCGA SARC -0.129; TCGA UCEC -0.199 |
hsa-miR-550a-5p | CX3CR1 | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; LUAD; LUSC; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.272; TCGA BRCA -0.183; TCGA CESC -0.373; TCGA COAD -0.374; TCGA HNSC -0.164; TCGA LUAD -0.367; TCGA LUSC -0.461; TCGA SARC -0.182; TCGA STAD -0.307; TCGA UCEC -0.398 |
hsa-miR-550a-5p | TIMP2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; OV; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.431; TCGA BRCA -0.073; TCGA CESC -0.174; TCGA COAD -0.404; TCGA ESCA -0.227; TCGA HNSC -0.159; TCGA LIHC -0.17; TCGA LUSC -0.359; TCGA OV -0.089; TCGA PAAD -0.163; TCGA THCA -0.161; TCGA STAD -0.198; TCGA UCEC -0.376 |
hsa-miR-550a-5p | ST6GALNAC6 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.194; TCGA BRCA -0.09; TCGA CESC -0.064; TCGA COAD -0.252; TCGA ESCA -0.258; TCGA HNSC -0.083; TCGA KIRC -0.06; TCGA KIRP -0.072; TCGA LGG -0.136; TCGA LIHC -0.182; TCGA LUAD -0.219; TCGA LUSC -0.208; TCGA SARC -0.079; TCGA STAD -0.227; TCGA UCEC -0.152 |
hsa-miR-550a-5p | IGSF21 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LUAD; LUSC; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.457; TCGA BRCA -0.447; TCGA CESC -0.198; TCGA COAD -0.444; TCGA ESCA -0.289; TCGA LGG -0.223; TCGA LUAD -0.142; TCGA LUSC -0.233; TCGA SARC -0.199; TCGA THCA -0.358; TCGA STAD -0.156 |
hsa-miR-550a-5p | PDGFRA | 10 cancers: BLCA; CESC; COAD; HNSC; LIHC; LUAD; LUSC; OV; STAD; UCEC | MirTarget | TCGA BLCA -0.451; TCGA CESC -0.33; TCGA COAD -0.304; TCGA HNSC -0.133; TCGA LIHC -0.311; TCGA LUAD -0.097; TCGA LUSC -0.344; TCGA OV -0.232; TCGA STAD -0.184; TCGA UCEC -0.479 |
hsa-miR-550a-5p | ADCYAP1 | 10 cancers: BLCA; CESC; COAD; ESCA; LIHC; LUSC; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.645; TCGA CESC -0.253; TCGA COAD -0.684; TCGA ESCA -0.635; TCGA LIHC -0.345; TCGA LUSC -0.364; TCGA PAAD -0.413; TCGA SARC -0.312; TCGA STAD -0.787; TCGA UCEC -0.587 |
hsa-miR-550a-5p | MAN1A1 | 9 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LUSC; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.185; TCGA CESC -0.164; TCGA HNSC -0.198; TCGA KIRC -0.209; TCGA KIRP -0.167; TCGA LUSC -0.342; TCGA SARC -0.138; TCGA STAD -0.113; TCGA UCEC -0.371 |
hsa-miR-550a-5p | SCARA3 | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LGG; LUAD; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.203; TCGA BRCA -0.072; TCGA COAD -0.425; TCGA ESCA -0.286; TCGA KIRC -0.291; TCGA LGG -0.102; TCGA LUAD -0.287; TCGA PAAD -0.283; TCGA THCA -0.403; TCGA STAD -0.512; TCGA UCEC -0.267 |
hsa-miR-550a-5p | TSPAN9 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.074; TCGA BRCA -0.139; TCGA CESC -0.107; TCGA COAD -0.114; TCGA ESCA -0.191; TCGA LIHC -0.083; TCGA LUAD -0.139; TCGA LUSC -0.131; TCGA OV -0.139; TCGA PAAD -0.197; TCGA STAD -0.14; TCGA UCEC -0.104 |
hsa-miR-550a-5p | WDFY4 | 9 cancers: BLCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; THCA | mirMAP | TCGA BLCA -0.367; TCGA CESC -0.266; TCGA COAD -0.319; TCGA ESCA -0.237; TCGA LIHC -0.185; TCGA LUAD -0.204; TCGA LUSC -0.563; TCGA PAAD -0.482; TCGA THCA -0.426 |
hsa-miR-550a-5p | KIAA0513 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; STAD; UCEC | mirMAP | TCGA BLCA -0.326; TCGA CESC -0.18; TCGA COAD -0.169; TCGA ESCA -0.27; TCGA HNSC -0.16; TCGA LGG -0.214; TCGA LIHC -0.118; TCGA LUAD -0.137; TCGA LUSC -0.254; TCGA STAD -0.256; TCGA UCEC -0.14 |
hsa-miR-550a-5p | WTIP | 10 cancers: BLCA; BRCA; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; THCA; STAD | mirMAP | TCGA BLCA -0.08; TCGA BRCA -0.135; TCGA COAD -0.272; TCGA ESCA -0.173; TCGA LIHC -0.24; TCGA LUAD -0.156; TCGA LUSC -0.182; TCGA PAAD -0.28; TCGA THCA -0.248; TCGA STAD -0.176 |
hsa-miR-550a-5p | C9orf3 | 10 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LIHC; LUAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.177; TCGA BRCA -0.052; TCGA CESC -0.281; TCGA ESCA -0.126; TCGA KIRC -0.194; TCGA LIHC -0.073; TCGA LUAD -0.062; TCGA SARC -0.16; TCGA STAD -0.13; TCGA UCEC -0.168 |
hsa-miR-550a-5p | GFRA1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.68; TCGA BRCA -0.306; TCGA CESC -0.583; TCGA COAD -0.548; TCGA ESCA -0.633; TCGA HNSC -0.382; TCGA LGG -0.386; TCGA LIHC -0.493; TCGA LUAD -0.583; TCGA LUSC -0.587; TCGA OV -0.29; TCGA PAAD -0.27; TCGA STAD -1.013; TCGA UCEC -0.663 |
hsa-miR-550a-5p | DST | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.088; TCGA CESC -0.185; TCGA COAD -0.142; TCGA ESCA -0.18; TCGA HNSC -0.112; TCGA LGG -0.079; TCGA SARC -0.115; TCGA THCA -0.269; TCGA STAD -0.322; TCGA UCEC -0.374 |
hsa-miR-550a-5p | TSPAN18 | 10 cancers: BLCA; CESC; COAD; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.555; TCGA CESC -0.238; TCGA COAD -0.29; TCGA LIHC -0.253; TCGA LUAD -0.141; TCGA LUSC -0.183; TCGA OV -0.176; TCGA PAAD -0.247; TCGA STAD -0.307; TCGA UCEC -0.499 |
hsa-miR-550a-5p | TPPP | 11 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LGG; LUAD; LUSC; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.38; TCGA BRCA -0.093; TCGA CESC -0.27; TCGA ESCA -0.216; TCGA KIRC -0.251; TCGA LGG -0.23; TCGA LUAD -0.382; TCGA LUSC -0.204; TCGA SARC -0.314; TCGA STAD -0.216; TCGA UCEC -0.246 |
hsa-miR-550a-5p | TOM1L2 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; STAD; UCEC | mirMAP | TCGA BLCA -0.07; TCGA BRCA -0.104; TCGA CESC -0.242; TCGA ESCA -0.184; TCGA HNSC -0.151; TCGA KIRC -0.231; TCGA LGG -0.176; TCGA LUAD -0.199; TCGA LUSC -0.105; TCGA OV -0.08; TCGA STAD -0.242; TCGA UCEC -0.146 |
hsa-miR-550a-5p | RTN4RL1 | 9 cancers: BRCA; COAD; ESCA; KIRP; LGG; LIHC; LUAD; STAD; UCEC | MirTarget | TCGA BRCA -0.238; TCGA COAD -0.639; TCGA ESCA -0.292; TCGA KIRP -0.262; TCGA LGG -0.252; TCGA LIHC -0.182; TCGA LUAD -0.533; TCGA STAD -0.279; TCGA UCEC -0.308 |
hsa-miR-550a-5p | GCNT4 | 11 cancers: CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; SARC; THCA; STAD; UCEC | MirTarget | TCGA CESC -0.31; TCGA COAD -0.372; TCGA ESCA -0.444; TCGA HNSC -0.228; TCGA KIRC -0.421; TCGA LUAD -0.18; TCGA LUSC -0.266; TCGA SARC -0.338; TCGA THCA -0.297; TCGA STAD -0.472; TCGA UCEC -0.44 |
Enriched cancer pathways of putative targets